| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0641-6182-25 | 0641-6182 | HUMAN PRESCRIPTION DRUG | Orphenadrine citrate | Orphenadrine citrate | INJECTION | INTRAMUSCULAR; INTRAVENOUS | 20030428 | N/A | ANDA | ANDA040463 | Hikma Pharmaceuticals USA Inc. | ORPHENADRINE CITRATE | 60 mg/2mL | 25 BOX in 1 BOX (0641-6182-25) / 10 VIAL in 1 BOX (0641-6182-10) / 2 mL in 1 VIAL (0641-6182-01) |
| 70518-3823-0 | 70518-3823 | HUMAN PRESCRIPTION DRUG | Orphenadrine citrate | Orphenadrine citrate | INJECTION | INTRAMUSCULAR; INTRAVENOUS | 20230807 | N/A | ANDA | ANDA040463 | REMEDYREPACK INC. | ORPHENADRINE CITRATE | 60 mg/2mL | 10 VIAL in 1 BOX (70518-3823-0) / 2 mL in 1 VIAL (70518-3823-1) |